The Global Biosimilars And Biologics Industry is on track for a remarkable trajectory, fueled by a growing demand for these advanced therapies. According to a recent analysis, the market is expected to surge from US$520.9 billion in 2024 to a staggering US$1,060.7 billion by 2034. This translates to a robust Compound Annual Growth Rate (CAGR) …
Tag Archives: Global Biosimilars And Biologics
Global Biosimilars And Biologics Industry on Track for a US$95 Billion Valuation, Fueled by a 15.5% CAGR According to FMI
The Global Biosimilars and Biologics Industry is expected to grow at a CAGR of 15.5% during the period 2022-2032. The market is valued at US$ 22,490.62 Mn in 2022 and is expected to reach a valuation of US$ 95,021.37 Mn by 2032. FMI, in its business report, elaborates on the historical and current scenario of the Global …